Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED)

Inclusion Criteria

• •Patients with chronic hepatitis C patients (CHC) who met all of the following criteria:
• •At least 20 years of age and willing to sign an informed consent
• •Patients who can practice contraception
• •Patients who are classified either as relapsers or non-responders.
• •Weight between 45 and 100 kg
• •Patients willing to be hospitalized for 3 days after the start of treatment
• •Patients with positive HCV-RNA
• •Serum ALT level: Over 60 IU/L, equal to or less than 150 IU/L
• •Neutrophil count: equal to or more than 1,200 /mm\^3
• •Platelet count：equal to or more than 100,000/mm\^3